Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • EXCHANGES AND MARKET REGULATION—N.Y. Sup.: New York and Polymarket sue each other over prediction markets trading
    • BLOCKCHAIN—CFTC updates FAQs on margin collateral and recordkeeping
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FRAUD AND MANIPULATION—S.D.N.Y.: Shareholder action dismissed for failure to allege actionable false statements
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FRAUD AND MANIPULATION—S.D.N.Y.: Statements about drilling rigs’ condition weren’t made with scienter
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • VITAL BRIEFING—Extension of China tariff truce agreed to ahead of Xi, Trump summit
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • WORTH NOTING—Other litigation, regulatory activity, and industry news
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Securities Regulation Daily Wrap Up, FRAUD AND MANIPULATION—S.D.N.Y.: Shareholder action dismissed for failure to allege actionable false statements, (Sep 25, 2026)

    Law Firms Mentioned:Glancy Prongay Wolke & Rotter LLP | Labaton Keller Sucharow LLP | Paul, Weiss, Rifkind, Wharton & Garrison LLP
    Organizations Mentioned:City Pension Fund for Firefighters and Police Officers in the City of Tampa | Paul Weiss Rifkind Wharton & Garrison, LLP | Regeneron Pharmaceuticals | Regeneron Pharmaceuticals, Inc.

    By John Filar Atwood

    The court concluded that the plaintiff failed to plausibly allege the scheme was employed in connection with the purchase or sale of securities, with the requisite scienter.

    The Southern District of New York district court has dismissed a shareholder ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use